PATENT CLAIM ANALYSIS

Application Number: 16075904
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "365000"]

Abstract:
The present application discloses a pharmaceutical preparation comprising a de-epoxidized epothilone derivative, and especially relates to a preparation formulation of a compound with reduced allergens and toxicity; and also relates to the use thereof in the treatment of tumours, especially the use thereof in the treatment of solid tumours that are resistant to and fail to respond to other conventional chemotherapeutic agents, as well as the use thereof in the treatment of cancers alone or in combination with other tumour drugs or auxiliary drugs.

Claim (Index 3):
The pharmaceutical formulation according to  claim 24 , wherein the solubilizing agent is a combination of polyoxyethylenated castor oil and propylene glycol; particularly, the excipient consists of absolute ethanol:polyoxyethylenated castor oil:propylene glycol=5:2:3 (v/v).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.7451
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12763991', '13077766', '09863035', '13125303', '12855889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7119674744297309
- 35 USC 102 Novelty (BERT): 0.5083116487477717
- Combined Prediction Score: 0.6916018918615349
- Mean Citation Score: 248.371896
- Max Citation Score: 256.2341
- Similarity Product: 176.25297729636432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test